Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
EMBO Reports
|
October 28, 2003
Keeping hopes high
Jocelyne Demengeot, Shohei Hori
Journal of Immunology (Baltimore, Md. : 1950)
|
August 5, 2006
Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells"
Santiago Zelenay, Jocelyne Demengeot
Current Problems in Dermatology
|
November 14, 2017
The Immunogenicity of Biologic Therapies
Sandra Garcês, Jocelyne Demengeot
Frontiers in Public Health
|
February 6, 2026
Preventing laboratory-acquired <i>Toxoplasma gondii</i> infection: literature review and case-based post-exposure prophylaxis proposal
Diana Póvoas, Jocelyne Demengeot, Fernando Maltez
Journal of Autoimmunity
|
February 27, 2003
Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice
Déborah Braun, Pedro Geraldes, Jocelyne Demengeot
International Immunology
|
April 6, 2002
IFN-alpha/beta enhances BCR-dependent B cell responses
Déborah Braun, Iris Caramalho, Jocelyne Demengeot
Future Microbiology
|
December 2, 2014
Escherichia coli adaptation to the gut environment: a constant fight for survival
Isabel Gordo, Jocelyne Demengeot, Karina Xavier
Blood
|
June 1, 2013
Naturally secreted immunoglobulins limit B1 and MZ B-cell numbers through a microbiota-independent mechanism
Andreia C Lino, Elodie Mohr, Jocelyne Demengeot
European Journal of Immunology
|
May 1, 2002
CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice
Shohei Hori, Thiago L Carvalho, Jocelyne Demengeot
Nature Communications
|
December 1, 2015
Adaptive immunity increases the pace and predictability of evolutionary change in commensal gut bacteria
João Barroso-Batista, Jocelyne Demengeot, Isabel Gordo
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
EMBO Reports
|
October 28, 2003
Keeping hopes high
Jocelyne Demengeot, Shohei Hori
Journal of Immunology (Baltimore, Md. : 1950)
|
August 5, 2006
Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells"
Santiago Zelenay, Jocelyne Demengeot
Current Problems in Dermatology
|
November 14, 2017
The Immunogenicity of Biologic Therapies
Sandra Garcês, Jocelyne Demengeot
Frontiers in Public Health
|
February 6, 2026
Preventing laboratory-acquired <i>Toxoplasma gondii</i> infection: literature review and case-based post-exposure prophylaxis proposal
Diana Póvoas, Jocelyne Demengeot, Fernando Maltez
Journal of Autoimmunity
|
February 27, 2003
Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice
Déborah Braun, Pedro Geraldes, Jocelyne Demengeot
International Immunology
|
April 6, 2002
IFN-alpha/beta enhances BCR-dependent B cell responses
Déborah Braun, Iris Caramalho, Jocelyne Demengeot
Future Microbiology
|
December 2, 2014
Escherichia coli adaptation to the gut environment: a constant fight for survival
Isabel Gordo, Jocelyne Demengeot, Karina Xavier
Blood
|
June 1, 2013
Naturally secreted immunoglobulins limit B1 and MZ B-cell numbers through a microbiota-independent mechanism
Andreia C Lino, Elodie Mohr, Jocelyne Demengeot
European Journal of Immunology
|
May 1, 2002
CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice
Shohei Hori, Thiago L Carvalho, Jocelyne Demengeot
Nature Communications
|
December 1, 2015
Adaptive immunity increases the pace and predictability of evolutionary change in commensal gut bacteria
João Barroso-Batista, Jocelyne Demengeot, Isabel Gordo
Page
of 7